Investigation on the safety of regular plasma donors aged 56-60 years
10.13303/j.cjbt.issn.1004-549x.2024.07.016
- VernacularTitle:56～60周岁固定献血浆者安全性调查分析
- Author:
Yang GAO
1
;
Kecheng DONG
2
;
Mingli MA
3
;
Yan DONG
3
;
Donghong FANG
4
;
Yumeng SU
1
;
Rong ZHOU
1
;
Demei DONG
1
Author Information
1. Beijing Tiantan Biological Products Co., Ltd, Beijing 100000, China
2. Shifang Rongsheng Apheresis Plasma Co., Ltd
3. Sinopharm Lanzhou Biopharmaceuticals Co., Ltd
4. Sinopharm Shanghai Blood Products Co., Ltd
- Publication Type:Journal Article
- Keywords:
plasma;
plasma donors aged 56 to 60;
adverse reaction to plasma donation;
age
- From:
Chinese Journal of Blood Transfusion
2024;37(7):812-815
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To investigate the safety of regular plasma donors aged 55 to 60, so as to provide reference for retention and recruitment of elderly plasma donors in China. 【Methods】 Plasma donors from 9 blood products manufacturing enterprises from 2018 to 2020 and the local general population were selected as the research objects. The total protein level, albumin and globulin ratio(ALB/GLB, A/G) and adverse reactions of plasma donation of regular plasma donors and local general population were retrospectively analyzed. 【Results】 The total protein level (g/L) and A/G of plasma donors aged 56 to 60 and the general population were 61.21±5.62 vs 60.04±6.93 and 1.610±0.299 vs 1.635±0.330, respectively, and the differences were statistically significant. The total protein level of regular plasma donors was higher than that of general population, but A/G was slightly lower than that of general population. From 2018 to 2020, there were a total of 23 056 302 plasma donations in 108 plasma stations, and adverse reactions occurred in 20 932 donations, with a total incidence of 0.09%, with no serious adverse reactions. 【Conclusion】 It is safe for regular plasma donors aged 55 to 60 to donate plasma, and the retention of them can alleviate the pressure of plasma supply.
